REGISTERED
on 23 Jul 2019
Last Applicant/ Owned by
DK-8200 Aarhus N
DK
Serial Number
79238525 filed on 18th May 2018
Registration Number
5809155 registered on 23rd Jul 2019
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
NMD PHARMA NEUROMUSCULAR DISORDERS
Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical-pharmaceutical preparations for the treatment of rare and genetic diseases; chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders; chemical-pharmaceutical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by compromised skeletal muscle excitability; diagnostic preparations for medical purposes; reagents for medical purposes [ and for research ] ; preparations for analysis for medical [ and research ] purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; pharmaceutical and medical preparations for acute hospital care, namely, chemical-pharmaceutical preparations for the reversal of neuromuscular blockade, chemical-pharmaceutical preparations for the treatment of intensive care unit acquired muscle weakness, chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by infections
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79238525
Mark Type
No Service Mark
Attorney Docket Number
No 3515677-0003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.07.21 -
Diamonds that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Jul 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 09th Sep 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 03rd Sep 2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 26th Jul 2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 06th Dec 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Nov 2019 | CORRECTION UNDER SECTION 7 - PROCESSED |
| 21st Nov 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 14th Nov 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 14th Nov 2019 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| 14th Nov 2019 | FINAL DISPOSITION PROCESSED |